These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 29133389)
1. Selective killing of Xiong M; Bao Y; Xu X; Wang H; Han Z; Wang Z; Liu Y; Huang S; Song Z; Chen J; Peek RM; Yin L; Chen LF; Cheng J Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12675-12680. PubMed ID: 29133389 [TBL] [Abstract][Full Text] [Related]
2. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury. Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309 [TBL] [Abstract][Full Text] [Related]
3. Huang Y; Hang X; Jiang X; Zeng L; Jia J; Xie Y; Li F; Bi H Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936098 [No Abstract] [Full Text] [Related]
4. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF Cancer Lett; 2014 Dec; 355(1):106-12. PubMed ID: 25218349 [TBL] [Abstract][Full Text] [Related]
5. Role of antimicrobial peptides expressed by host cells upon infection by Helicobacter pylori. Gopal R; Jeong E; Seo CH; Park Y Protein Pept Lett; 2014; 21(10):1057-64. PubMed ID: 25001211 [TBL] [Abstract][Full Text] [Related]
6. A pH-Responsive Persistent Luminescence Nanozyme for Selective Imaging and Killing of Yan LX; Wang BB; Zhao X; Chen LJ; Yan XP ACS Appl Mater Interfaces; 2021 Dec; 13(51):60955-60965. PubMed ID: 34904434 [No Abstract] [Full Text] [Related]
7. Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Guo Z; Hou Y; Tian Y; Tian J; Hu J; Zhang Y ACS Appl Mater Interfaces; 2024 Oct; 16(39):51981-51993. PubMed ID: 39292612 [No Abstract] [Full Text] [Related]
8. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. Makobongo MO; Einck L; Peek RM; Merrell DS PLoS One; 2013; 8(7):e68917. PubMed ID: 23935905 [TBL] [Abstract][Full Text] [Related]
9. Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model. Narayana JL; Huang HN; Wu CJ; Chen JY Biomaterials; 2015 Aug; 61():41-51. PubMed ID: 25996410 [TBL] [Abstract][Full Text] [Related]
10. The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori. Makobongo MO; Gancz H; Carpenter BM; McDaniel DP; Merrell DS Antimicrob Agents Chemother; 2012 Jan; 56(1):378-90. PubMed ID: 22064541 [TBL] [Abstract][Full Text] [Related]
11. β-Defensins in the Fight against Helicobacter pylori. Pero R; Coretti L; Nigro E; Lembo F; Laneri S; Lombardo B; Daniele A; Scudiero O Molecules; 2017 Mar; 22(3):. PubMed ID: 28272373 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori. Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893 [TBL] [Abstract][Full Text] [Related]
13. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities. Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106 [TBL] [Abstract][Full Text] [Related]
14. pH-Responsive Polymeric Micelle Dynamic Complexes for Selective Killing of Tan J; Fang Y; Yang C; Tay J; Tan N; Krishnan NDB; Chua BL; Zhao Y; Chen Y; Hedrick JL; Yang YY Biomacromolecules; 2023 Dec; 24(12):5551-5562. PubMed ID: 37828909 [No Abstract] [Full Text] [Related]
15. Anti-Helicobacter pylori potential of artemisinin and its derivatives. Goswami S; Bhakuni RS; Chinniah A; Pal A; Kar SK; Das PK Antimicrob Agents Chemother; 2012 Sep; 56(9):4594-607. PubMed ID: 22687518 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190 [TBL] [Abstract][Full Text] [Related]
17. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation. Thamphiwatana S; Gao W; Obonyo M; Zhang L Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori. Gavrish E; Shrestha B; Chen C; Lister I; North EJ; Yang L; Lee RE; Han A; Williams B; Charnuska D; Coleman K; Lewis K; LaFleur MD Antimicrob Agents Chemother; 2014 Jun; 58(6):3255-60. PubMed ID: 24687512 [TBL] [Abstract][Full Text] [Related]
19. Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Olleik H; Baydoun E; Perrier J; Hijazi A; Raymond J; Manzoni M; Dupuis L; Pauleau G; Goudard Y; Villéon B; Goin G; Sockeel P; Choudhary MI; Pasquale ED; Nadeem-Ul-Haque M; Ali H; Khan AI; Shaheen F; Maresca M Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614561 [No Abstract] [Full Text] [Related]
20. Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD. Mukaisho K; Hagiwara T; Nakayama T; Hattori T; Sugihara H World J Gastroenterol; 2014 Sep; 20(34):11962-5. PubMed ID: 25232231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]